Drastic Ca2+ sensitization of myofilament associated with a small structural change in troponin I in inherited restrictive cardiomyopathy

被引:67
作者
Yumoto, F
Lu, QW
Morimoto, S [1 ]
Tanaka, H
Kono, N
Nagata, K
Qjima, T
Takahashi-Yanaga, F
Miwa, Y
Sasaguri, T
Nishita, K
Tanokura, M
Ohtsuki, I
机构
[1] Kyushu Univ, Grad Sch Med, Dept Clin Pharmacol, Fukuoka, Japan
[2] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan
[3] Jikei Univ, Sch Med, Dept Physiol 2, Tokyo, Japan
[4] Hokkaido Univ, Grad Sch Fisheries Sci, Lab Biochem & Biotechnol, Hakodate, Hokkaido, Japan
关键词
troponin; inherited cardiomyopathy; protein function and structure; CD; NMR;
D O I
10.1016/j.bbrc.2005.10.116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
bacterially expressed and purified these human cTnI mutants and examined their functional and structural consequences. Inserting the human cTnI into skinned cardiac muscle fibers showed that these mutations had much greater Ca2+ sensitizing effects on force generation than the cTnI mutations in hypertrophic cardiomyopathy (HCM). The mutation K178E in the second actin-tropomyosin (Tm) binding region showed a particularly potent Ca2+-sensitizing effect among the six RCM-causing mutations nuclear magnetic resonance spectroscopy revealed that this Mutation does not extensively affect the Structure of the whole cTnI molecule, but induces all unexpectedly subtle change in the structure of a region around the Mutated residue. The results indicate that the K178E mutation has a localized effect on a structure that is critical to the regulatory function of the second actin-Tin binding region of cTnI. The present study also Suggests that both HCM and RCM involving cTnI Mutations share a common feature of increased Ca2+ sensitivity of cardiac myofilament, but more severe change in Ca2+ sensitivity is associated with the clinical phenotype of RCM. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1519 / 1526
页数:8
相关论文
共 42 条
[1]  
AUSONI S, 1994, J BIOL CHEM, V269, P339
[2]   IDIOPATHIC DILATED CARDIOMYOPATHY [J].
DEC, GW ;
FUSTER, V .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (23) :1564-1575
[3]   NMRPIPE - A MULTIDIMENSIONAL SPECTRAL PROCESSING SYSTEM BASED ON UNIX PIPES [J].
DELAGLIO, F ;
GRZESIEK, S ;
VUISTER, GW ;
ZHU, G ;
PFEIFER, J ;
BAX, A .
JOURNAL OF BIOMOLECULAR NMR, 1995, 6 (03) :277-293
[4]   TROPONIN .I. PREPARATION AND PHYSIOLOGICAL FUNCTION [J].
EBASHI, S ;
KODAMA, A ;
EBASHI, F .
JOURNAL OF BIOCHEMISTRY, 1968, 64 (04) :465-&
[5]   NEW PROTEIN COMPONENT PARTICIPATING IN SUPERPRECIPITATION OF MYOSIN B [J].
EBASHI, S ;
EBASHI, F .
JOURNAL OF BIOCHEMISTRY, 1964, 55 (06) :604-&
[6]   C-terminal truncation of cardiac troponin I causes divergent effects on ATPase and force - Implications for the pathophysiology of myocardial stunning [J].
Foster, DB ;
Noguchi, T ;
VanBuren, P ;
Murphy, AM ;
Van Eyk, JE .
CIRCULATION RESEARCH, 2003, 93 (10) :917-924
[7]   Mutations in human cardiac Troponin I that are associated with restrictive cardiomyopathy affect basal ATPase activity and the calcium sensitivity of force development [J].
Gomes, AV ;
Liang, JS ;
Potter, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (35) :30909-30915
[8]   Molecular and cellular aspects of troponin cardiomyopathies [J].
Gomes, AV ;
Potter, JD .
CARDIAC ENGINEERING: FROM GENES AND CELLS TO STRUCTURE AND FUNCTION, 2004, 1015 :214-224
[9]   Functional consequences of the deletion mutation ΔGlu160 in human cardiac troponin T [J].
Harada, K ;
Takahashi-Yanaga, F ;
Minakami, R ;
Morimoto, S ;
Ohtsuki, I .
JOURNAL OF BIOCHEMISTRY, 2000, 127 (02) :263-268
[10]   EFFECT OF REMOVAL AND RECONSTITUTION OF TROPONIN-C AND TROPONIN-I ON THE CA2+-ACTIVATED TENSION DEVELOPMENT OF SINGLE GLYCERINATED RABBIT SKELETAL-MUSCLE FIBERS [J].
HATAKENAKA, M ;
OHTSUKI, I .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 205 (03) :985-993